Proteomic approaches in brain research and neuropharmacology

European Journal of Pharmacology

Volumn 500, Issue 1-3 SPEC. ISS., 2004, Pages 385-398

  Vercauteren, Freya G G ^a,b   Bergeron, John J M ^c   Vandesande, Frans ^b   Arckens, Lut ^b   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Reseau Proteomique Montreal M   (Canada)

Author keywords

Alzheimer's disease; Human Proteome Organization; Neuropharmacology; Neuroscience; Proteomics; Schizophrenia

Indexed keywords

ALCOHOL DEHYDROGENASE; ALDEHYDE REDUCTASE; ANTIOXIDANT; BETA ACTIN; BETA TUBULIN; CARBONATE DEHYDRATASE I; CARBONYL REDUCTASE; CITRATE SYNTHASE; CREATINE KINASE; ENOLASE; FASCIN; GLUTAMATE AMMONIA LIGASE; GLUTATHIONE SYNTHASE; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 60; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; ISOCITRATE DEHYDROGENASE; LAMININ RECEPTOR; LIM PROTEIN; MARKER; MITOGEN ACTIVATED PROTEIN KINASE 1; NEURON SPECIFIC ENOLASE; PHOSPHOGLUCOMUTASE; PROTEIN; SEPTIN; SERUM ALBUMIN; SYNAPTOTAGMIN; TRIOSEPHOSPHATE ISOMERASE; UBIQUITIN;

ALZHEIMER DISEASE; BRAIN; BRAIN TISSUE; CELL ORGANELLE; DATA ANALYSIS; DEGENERATIVE DISEASE; DNA MODIFICATION; DOWN SYNDROME; GENE EXPRESSION; GENE TECHNOLOGY; GENOMICS; HUMAN; NEUROPHARMACOLOGY; NONHUMAN; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; SCHIZOPHRENIA;

ALZHEIMER DISEASE; ANIMALS; BRAIN; DOWN SYNDROME; HUMANS; NEURODEGENERATIVE DISEASES; NEUROPHARMACOLOGY; PROTEOMICS; SCHIZOPHRENIA;

EID: 4644352414     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.039     Document Type: Review

References (97)

1. R. Aebersold, and M. Mann Mass spectrometry-based proteomics Nature 422 2003 198 207
2. M.Y. Aksenov, M.V. Aksenova, D.A. Butterfield, J.W. Geddes, and W.R. Markesbery Protein oxidation in the brain in Alzheimer's disease Neuroscience 103 2001 373 383
3. L. Anderson, and J. Seilhamer A comparison of selected mRNA and protein abundances in human liver Electrophoresis 18 1997 533 537
4. D.S. Auld, T.J. Kornecook, S. Bastianetto, and R. Quirion Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies Prog. Neurosci. 68 2002 209 245
5. G. Baggerman, P. Verleyen, E. Clynen, J. Huybrechts, A. De Loof, and L. Schoofs Peptidomics J. Chromatogr., B 803 2004 3 16
6. M. Bajo, J. Fruehauf, S.H. Kim, M. Fountoulakis, and G. Lubec Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex Proteomics 2 2002 1539 1546
7. B. Balcz, L. Kirchner, N. Cairns, M. Fountoulakis, and G. Lubec Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease J. Neural Transm., Suppl. 61 2001 193 201
8. J. Bormann Electrophysiological characterization of diazepam binding inhibitor (DBI) on GABAA receptors Neuropharmacology 30 1991 1387 1389
9. S. Brunet, P. Thibault, E. Gagnon, P. Kearney, J.J.M. Bergeron, and M. Desjardins Organelle proteomics: looking at less to see more Trends Cell Biol. 12 2003 629 638
10. S. Buckingham Bioinformatics: programmed for success Nature 425 2003 209 215
11. D.A. Butterfield Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain Brain Res. 1000 2004 1 7
12. A. Castegna, M. Aksenov, M. Aksenova, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Markesbery, and D.A. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain: Part I. Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1 Free Radic. Biol. Med. 33 2002 562 571
13. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease brain J. Neurochem. 85 2003 1394 1401
14. M.S. Cheon, M. Fountoulakis, N.J. Cairns, M. Dierssen, K. Herkner, and G. Lubec Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease J. Neural Transm., Suppl. 61 2001 281 288
15. J. Choi, A.I. Levey, S.T. Weintraub, H.D. Rees, M. Gearing, L.S. Chin, and L. Li Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases J. Biol. Chem. 279 2004 13256 13264
16. P. Cutler Protein arrays: the current state-of-the-art Proteomics 3 2003 3 18
17. C. Debouck, and P.N. Goodfellow DNA microarrays in drug discovery and development Nat. Genet. 21 1999 48 50
18. P.F. Edgar, J.E. Douglas, C. Knight, G.J. Cooper, R.L. Faull, and R. Kydd Proteome map of the human hippocampus Hippocampus 9 1999 644 650
19. P.F. Edgar, S.J. Schonberger, B. Dean, R.L. Faull, R. Kydd, and G.J. Cooper A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals Mol. Psychiatry 4 1999 173 178
20. E. Engidawork, T. Gulesserian, M. Fountoulakis, and G. Lubec Aberrant protein expression in cerebral cortex of fetus with Down syndrome Neuroscience 122 2003 145 154
21. E. Engidawork, T. Gulesserian, M. Fountoulakis, and G. Lubec Expression of hypothetical proteins in human fetal brain: increased expression of hypothetical protein 28.5 kDa in Down syndrome, a clue for its tentative role Mol. Genet. Metab. 78 2003 295 301
22. M. Fountoulakis, E. Schuller, R. Hardmeier, P. Berndt, and G. Lubec Rat brain proteins: two-dimensional protein database and variations in the expression level Electrophoresis 20 1999 3572 3579
23. M. Fountoulakis, R. Hardmeier, H. Hoger, and G. Lubec Postmortem changes in the level of brain proteins Exp. Neurol. 167 2001 86 94
24. M. Fountoulakis, J.F. Juranville, M. Dierssen, and G. Lubec Proteomic analysis of the fetal brain Proteomics 2 2002 1547 1576
25. B. Franzen, Y. Yang, D. Sunnemark, M. Wickman, J. Ottervald, M. Oppermann, and K. Sandberg Dihydropyrimidinase related protein-2 as a biomarker for temperature and time dependent post mortem changes in the mouse brain proteome Proteomics 3 2003 1920 1929
26. E. Gagnon, S. Duclos, C. Rondeau, E. Chevet, P.H. Cameron, O. Steele-Mortimer, J. Paiement, J.J. Bergeron, and M. Desjardins Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages Cell 110 2002 119 131
27. C. Gauss, M. Kalkum, M. Lowe, H. Lehrach, and J. Klose Analysis of the mouse proteome: I. Brain proteins: separation by two-dimensional electrophoresis and identification by mass spectrometry and genetic variation Electrophoresis 20 1999 575 600
28. A. Goffeau, B.G. Barrell, H. Bussey, and R.W. Davis Life with 6000 genes Science 274 1996 563 567
29. S. Greber, G. Lubec, N. Cairns, and M. Fountoulakis Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease Electrophoresis 20 1999 928 934
30. T. Gulesserian, E. Engidawork, M. Fountoulakis, and G. Lubec Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome J. Neural Transm., Suppl. 61 2001 71 84
31. S.P. Gygi, and R. Aebershold Mass spectrometry and proteomics Curr. Opin. Chem. Biol. 4 2000 489 494
32. S.P. Gygi, B. Rist, S.A. Gerber, F. Turecek, M.H. Gelb, and R. Aebershold Quantitative analysis of protein mixtures using isotope coded affinity tags Nat. Biotechnol. 17 1999 994 999
33. S. Hanash Disease proteomics Nature 422 2003 226 232
34. D. Hinerfeld, M.D. Traini, R.P. Weinberger, B. Cochran, S.R. Doctrow, J. Harry, and S. Melov Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice J. Neurochem. 88 2004 657 667
35. J.S. Hu, M. Durst, R. Kerb, V. Truong, J.T. Ma, E. Khurgin, D. Balabon, T.R. Gingeras, and B.B. Hoffman Analysis of drug pharmacology towards predicting drug behavior by expression profiling using high-density oligonucleotide arrays Ann. N.Y. Acad. Sci. 919 2000 9 15
36. N.L. Johnston-Wilson, C.D. Sims, J.P. Hofmann, L. Anderson, A.D. Shore, E.F. Torrey, and R.H. Yolken Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium Mol. Psychiatry 5 2000 142 149
37. S.W. Kang, I.C. Baines, and S.G. Rhee Characterization of a mammalian peroxiredoxin that contains one conserved cysteine J. Biol. Chem. 273 1998 6303 6311
38. K. Karlsson, N. Cairns, G. Lubec, and M. Fountoulakis Enrichment of human brain proteins by heparin chromatography Electrophoresis 20 1999 2970 2976
39. S.H. Kim, N. Cairns, M. Fountoulakisc, and G. Lubec Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease Neurosci. Lett. 300 2001 41 44
40. S.H. Kim, M. Fountoulakis, N. Cairns, and G. Lubec Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome J. Neural Transm., Suppl. 61 2001 223 235
41. S.H. Kim, R. Vlkolinsky, N. Cairns, M. Fountoulakis, and G. Lubec The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease Life Sci. 68 2001 2741 2750
42. S.H. Kim, M. Fountoulakis, N.J. Cairns, and G. Lubec Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome Biochem. Biophys. Res. Commun. 296 2002 970 975
43. J.B. Klein, D. Gozal, W.M. Pierce, V. Thongboonkerd, J.A. Scherzer, L.R. Sachleben, S.Z. Guo, J. Cai, and E. Gozal Proteomic identification of a novel protein regulated in CA1 and CA3 hippocampal regions during intermittent hypoxia Respir. Physiol. Neurobiol. 136 2003 91 103
44. J. Klose, C. Nock, M. Herrmann, K. Stuhler, K. Marcus, M. Bluggel, E. Krause, L.C. Schalkwyk, S. Rastan, S.D. Brown, K. Bussow, H. Himmelbauer, and H. Lehrach Genetic analysis of the mouse brain proteome Nat. Genet. 30 2002 385 393
45. M.A. Korolainen, G. Goldsteins, I. Alafuzoff, J. Koistinaho, and T. Pirttila Proteomic analysis of protein oxidation in Alzheimer's disease brain Electrophoresis 23 2002 3428 3433
46. Z. Kouchi, H. Sorimachi, K. Suzuki, and S. Ishiura Proteasome inhibitors induce the association of Alzheimer's amyloid precursor protein with Hsc73 Biochem. Biophys. Res. Commun. 254 1999 804 810
47. K. Krapfenbauer, E. Engidawork, N. Cairns, M. Fountoulakis, and G. Lubec Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders Brain Res. 967 2003 152 160
48. K. Krapfenbauer, M. Fountoulakis, and G. Lubec A rat brain protein expression map including cytosolic and enriched mitochondrial and microsomal fractions Electrophoresis 24 2003 1847 1870
49. H. Langen, P. Berndt, D. Roder, N. Cairns, G. Lubec, and M. Fountoulakis Two-dimensional map of human brain proteins Electrophoresis 20 1999 907 916
50. K.W. Li, M.P. Hornshaw, R.C. Van Der Schors, R. Watson, S. Tate, B. Casetta, C.R. Jimenez, Y. Gouwenberg, E.D. Gundelfinger, K.H. Smalla, and A.B. Smit Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology J. Biol. Chem. 279 2004 987 1002
51. P. Liang, and A.B. Pardee Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction Science 257 1992 967 971
52. E.R. Marcotte, L.K. Srivastava, and R. Quirion cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease Pharmacol. Ther. 100 2003 63 74
53. L. Melton Proteomics in multiplex Nature 429 2004 101 107
54. K. Mirnics, and J. Pevsner Progress in the use of microarray technology to study the neurobiology of disease Nat. Neurosci. 7 2004 434 439
55. V.K. Mootha, J. Bunkenborg, J.V. Olsen, and M. Hjerrild Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria Cell 115 2003 629 640
56. D.D. Mosser, A.W. Caron, L. Bourget, C. Denis-Larose, and B. Massie Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis Mol. Cell. Biol. 17 1997 5317 5327
57. P.J. Muchowski, G. Schaffar, A. Sittler, E.E. Wanker, M.K. Hayer-Hartl, and F.U. Hartl Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils Proc. Natl. Acad. Sci. U. S. A. 97 2000 7841 7846
58. T. Oguri, I. Takahata, K. Katsuta, E. Nomura, M. Hidaka, and N. Inagaki Proteome analysis of rat hippocampal neurons by multiple large gel two-dimensional electrophoresis Proteomics 2 2002 666 672
59. J.V. Olsen, J.R. Andersen, P.A. Nielsen, M.L. Nielsen, D. Figeys, M. Mann, and J.R. Wisniewski HysTag - a novel proteomic quantification tool applied to differential display analysis of membrane proteins from distinct areas of mouse brain Mol. Cell. Proteomics 3 2004 82 92
60. S. Orchard, H. Hermjakob, R.K. Julian Jr., K. Runte, D. Sherman, J. Wojcik, W. Zhu, and R. Apweiler Common interchange standards for proteomics data: public availability of tools and schema Proteomics 4 2003 490 491
61. A. Pandey, and M. Mann Proteomics to study genes and genomes Nature 405 2000 837 846
62. L. Paulson, P. Martin, A. Persson, C.L. Nilsson, E. Ljung, A. Westman-Brinkmalm, P.S. Eriksson, K. Blennow, and P. Davidsson Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats J. Neurosci. Res. 71 2003 526 533
63. J. Quakenbush Data standards for «omic» science Nat. Biotechnol. 22 2004 613 614
64. T. Rabilloud Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains Proteomics 2 2002 3 10
65. Rat Genome Sequencing Project Consortium Genome sequence of the Brown Norway rat yields insights into mammalian evolution Nature 428 2004 493 521
66. C.G. Sagerstrom, B.I. Sun, and H.L. Sive Subtractive cloning: past, present, and future Annu. Rev. Biochem. 66 1997 751 783
67. S.J. Schonberger, P.F. Edgar, R. Kydd, R.L. Faull, and G.J. Cooper Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process Proteomics 1 2001 1519 1528
68. J.H. Shin, J.W. Yang, J.F. Juranville, M. Fountoulakis, and G. Lubec Evidence for existence of thirty hypothetical proteins in rat brain Proteome Sci. 2 2004 1
69. S.S. Sidhu, W.J. Fairbrother, and K. Deshayes Exploring protein-protein interactions with phage display ChemBioChem 4 2000 14 25
70. H.A. Skynner, T.W. Rosahl, M.R. Knowles, K. Salim, L. Reid, R. Cothliff, G. McAllister, and P.C. Guest Alterations of stress related proteins in genetically altered mice revealed by two-dimensional differential in-gel electrophoresis analysis Proteomics 2 2002 1018 1025
71. C.D. Smith, J.M. Carney, P.E. Starke-Reed, C.N. Oliver, E.R. Stadtman, R.A. Floyd, and W.R. Markesbery Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 88 1991 10540 10543
72. B.A. Soreghan, F. Yang, S.N. Thomas, J. Hsu, and A.J. Yang High-throughput proteomic-based identification of oxidatively induced protein carbonylation in mouse brain Pharm. Res. 20 2003 1713 1720
73. G.J. Stege, K. Renkawek, P.S. Overkamp, P. Verschuure, A.F. van Rijk, A. Reijnen-Aalbers, W.C. Boelens, G.J. Bosman, and W.W. de Jong The molecular chaperone αB-crystallin enhances amyloid β neurotoxicity Biochem. Biophys. Res. Commun. 262 1999 152 156
74. S.M. Stevens Jr., A.D. Zharikova, and L. Prokai Proteomic analysis of the synaptic plasma membrane fraction isolated from rat forebrain Brain Res. Mol. Brain. Res. 117 2003 116 128
75. R. Strohman Epigenesis: the missing beat in biotechnology? Biotechnology (N.Y.) 12 1994 156 164
76. M. Svensson, K. Skold, P. Svenningsson, and P.E. Andren Peptidomics-based discovery of novel neuropeptides J. Proteome Res. 2 2003 213 219
77. M. Taoka, A. Wakamiya, H. Nakayama, and T. Isobe Protein profiling of rat cerebella during development Electrophoresis 21 2000 1872 1879
78. C.M. Taylor, and S.E. Pfeiffer Enhanced resolution of glycosylphosphatidylinositol-anchored and transmembrane proteins from the lipid-rich myelin membrane by two-dimensional gel electrophoresis Proteomics 3 2003 1303 1312
79. C.M. Taylor, C.B. Marta, R.J. Claycomb, D.K. Han, M.N. Rasband, T. Coetzee, and S.E. Pfeiffer Proteomic mapping provides powerful insights into functional myelin biology Proc. Natl. Acad. Sci. 101 2004 4643 4648
80. The C. elegans Sequencing Consortium Genome sequence of the nematode C. elegans: a platform for investigating biology Science 282 1998 2012 2018
81. K. Tilleman, I. Stevens, K. Spittaels, C.V. Haute, S. Clerens, G. Van Den Bergh, H. Geerts, F. Van Leuven, F. Vandesande, and L. Moens Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view Proteomics 2 2002 94 104
82. K. Tilleman, C. Van den Haute, H. Geerts, F. van Leuven, E.L. Esmans, and L. Moens Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice Proteomics 2 2002 656 665
83. A. Tsugita, T. Kawakami, T. Uchida, T. Sakai, M. Kamo, T. Matsui, Y. Watanabe, T. Morimasa, K. Hosokawa, and T. Toda Proteome analysis of mouse brain: two-dimensional electrophoresis profiles of tissue proteins during the course of aging Electrophoresis 21 2000 1853 1871
84. T. Tsuji, A. Shiozaki, R. Kohno, K. Yoshizato, and S. Shimohama Proteomic profiling and neurodegeneration in Alzheimer's disease Neurochem. Res. 27 2002 1245 1253
85. G. Van den Bergh, and L. Arckens Fluorescent two-dimensional gel electrophoresis unveils the potential of gel-based proteomics Curr. Opin. Biotechnol. 15 2004 38 43
86. G. Van den Bergh, S. Clerens, L. Cnops, F. Vandesande, and L. Arckens Fluorescent two-dimensional difference gel electrophoresis and mass spectrometry identify age-related protein expression differences for the primary visual cortex of kitten and adult cat J. Neurochem. 85 2003 193 205
87. V.E. Velculescu, L. Zhang, B. Volgestein, and K.W. Kinzler Serial analysis of gene expression Science 270 1995 484 487
88. J.C. Venter, M.D. Adams, E.W. Myers, and P.W. Li The sequence of the human genome Science 291 2001 1304 1351
89. M. Vidal, and P. Legrain Yeast forward and reverse 'n'-hybrid systems Nucleic Acids Res. 27 1999 919 929
90. R. Vlkolinsky, N. Cairns, M. Fountoulakis, and G. Lubec Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer's disease Neurobiol. Aging 22 2001 547 553
91. M.P. Washburn, D. Wolters, and J.R. Yates Large-scale analysis of the yeast proteome by multidimensional protein identification technology Nat. Biotechnol. 19 2001 242 247
92. V.C. Wasinger, S.J. Cordwell, A. Cerpa-poljak, J.X. Yan, A.A. Gooley, M.R. Wilkins, M.W. Duncan, R. Harris, K.L. Williams, and I. Humphery-Smith Progress with gene-product mapping of the mollicutes: mycoplasma genitalium Electrophoresis 16 1995 1090 1094
93. R.H. Waterston, K. Lindblad-Toh, E. Birney, and J. Rogers Initial sequencing and comparative analysis of the mouse genome Nature 420 2002 520 562
94. B.C. Yoo, N. Cairns, M. Fountoulakis, and G. Lubec Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease Dement. Geriatr. Cogn. Disord. 12 2001 219 225
95. B.C. Yoo, M. Fountoulakis, N. Cairns, and G. Lubec Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome Electrophoresis 22 2001 172 179
96. B.C. Yoo, S.H. Kim, N. Cairns, M. Fountoulakis, and G. Lubec Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease Biochem. Biophys. Res. Commun. 280 2001 249 258
97. B.C. Yoo, R. Vlkolinsky, E. Engidawork, N. Cairns, M. Fountoulakis, and G. Lubec Differential expression of molecular chaperones in brain of patients with Down syndrome Electrophoresis 22 2001 1233 1241